Turkish version of the Hypertonia Assessment Tool for children with motor disorders
Turkish Translation , Validity and Reliability of the Hypertonia Assessment Tool in Children With Motor Disorders
This project will test a Turkish translation of the Hypertonia Assessment Tool to see if it works well for children and adolescents with neuromotor disorders such as cerebral palsy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 70 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Kastamonu University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT07267442 on ClinicalTrials.gov |
What this trial studies
This observational project translates the Hypertonia Assessment Tool into Turkish and then measures its reliability and validity in children with neuromotor disorders. Researchers will enroll participants under 18 who can follow verbal commands and who have not had recent botulinum toxin injections, surgery, or medication changes, and will apply the translated tool alongside routine clinical evaluations. Psychometric testing will include inter-rater reliability, test–retest reliability, and comparisons with established measures of tone and motor function. Results will determine whether the Turkish version reliably identifies hypertonia subtypes (spasticity, dystonia, rigidity) and is practical for clinical and research use in Turkey.
Who should consider this trial
Good fit: Ideal candidates are children and adolescents under 18 with a diagnosed neuromotor disorder (for example cerebral palsy) who can follow verbal commands and have not had recent botulinum toxin injections, surgery, or medication changes.
Not a fit: Children with other active systemic diseases, who cannot follow verbal instructions, or who had recent surgery, botulinum toxin A injections, or medication changes are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, clinicians in Turkey would have a validated Turkish tool to better identify and characterize abnormal muscle tone, which could improve therapy planning and tracking of treatment effects.
How similar studies have performed: Translations and psychometric validations of hypertonia and tone-assessment tools in other languages have generally shown good reliability and validity, so this approach follows established methods.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * as voluntary participation in the study, * a diagnosis of a neuromotor disorder under the age of 18, * sufficient cognitive ability to follow verbal commands Exclusion Criteria: * Patients with any other systemic disease, * Who had received botulinum toxin A injections or undergone surgery within the past three months, * Be unable to follow verbal instructions * Medical treatment had been modified within the last month
Where this trial is running
Ankara
- Gazi University — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Hidayet Cuha, PhD(c)
- Email: hcuha@kastamonu.edu.tr
- Phone: +90 534 646 01 06
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.